Le Travenues Technology Limited (NSE:IXIGO)

Market Cap	89.97B
Revenue (ttm)	10.65B
Net Income (ttm)	644.11M
Shares Out	390.11M
EPS (ttm)	1.65
PE Ratio	139.61
Forward PE	90.15
Dividend	n/a
Ex-Dividend Date	n/a

Volume	109,369
Average Volume	1,324,674
Open	235.85
Previous Close	233.75
Day's Range	227.05 - 237.75
52-Week Range	118.65 - 237.75
Beta	n/a
RSI	71.56
Earnings Date	Oct 16, 2025

About Revance Therapeutics

Le Travenues Technology Limited operates online travel aggregator (OTA) platforms in India. Its OTA platforms allow travellers to book train tickets, flight tickets, bus tickets, hotels and cabs; provide travel utility tools and services, including PNR status updates, AI-powered multilingual live train status, Siri shortcuts, and augmented reality for locating coach positions, deal comparison, travel information, flight bookings, airline ticket booking, automated web check-ins, fare alerts, seat availability alerts, running status updates, dela...

• Industry: Travel Services
• Sector: Consumer Discretionary
• Founded: 2006
• Employees: 486
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: IXIGO

Financial Performance

In 2024, Le Travenues Technology's revenue was 9.32 billion, an increase of 42.14% compared to the previous year's 6.56 billion. Earnings were 601.82 million, a decrease of -20.60%.